References
- Andrysek T. (2003). Impact of physical properties of formulations on bioavailability of active substance: current and novel drugs with cyclosporine. Mol Immunol, 39, 1061–1065.
- Gao P, Rush BD, Pfund WP, Huang T, Bauer JM, Morozowich W, Kuo MS, Hageman MJ. (2003). Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci, 92, 2386–2398.
- Kim C, Shin H, Yang S, Kim J, Oh Y. (2001). Once-a-day oral dosing regimen of cyclosporin A: combined therapy of cyclosporin A premicroemulsion concentrates and enteric coated solid-state premicroemulsion concentrates. Pharm Res, 18, 454–459.
- Kommuru TR, Ashraf M, Reddy IK. (1999). Stability and bioequivalence studies of two marketed formulations of coenzyme Q10 in beagle dogs. Chem Pharm Bull, 47, 1024–1028.
- Liao C, Jarowski CI. (1984). Dissolution rates of corticoid solutions dispersed on silicas. J Pharm Sci, 73, 401–403.
- Lyon W, Van den Brink O, Pepe S, Wowk M, Marasco S, Rosenfeldt FL. (2001). Similar therapeutic serum levels attained with emulsified and oil-based preparations of coenzyme Q10. Asia Pac J Clin Nutr, 10, 212–215.
- Nazzal S, Nuyan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. (2002). Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm, 240, 103–114.
- Pather I, Gupte SV, Khankari RK, Hontz J, Robinson JR, Eichman JD, Newton RM, Petterson J, Podczeck F, Clarke A, Booth S. (2001). The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci, 90, 987–995.
- Sharon WM, Mark ER, Real GG, John JD, Gary LP. (1982). Liquid chromatographic assay for retinal (Vitamin-A) and retinal analogs in therapeutic trials. Clin Chem, 28, 693–696.
- Sheth A, Jarowski CI. (1990). Use of powdered solutions to improve the dissolution rate of polythiazide tablets. Drug Dev Ind Pharm, 16, 769–777.
- Spireas S, Sadu S. (1988). Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm, 166, 177–188.
- Spireas S, Sadu S, Grover R. (1998). In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci, 87, 867–872.
- Spireas SS, Jarowski CI, Rohera BD. (1992). Powdered solution technology: principles and mechanism. Pharm Res, 9, 1351–1358.
- Taha EI, Al-Saidan S, Samy AM, Khan MA. (2004). Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm, 285, 109–119.
- Takashima Y, Yuasa H, Kanaya Y, Nomura I, Shinozawa K. (1999). Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate). Int J Pharm, 187, 125–135.
- Yang KY, Glemza R, Jarowski CI. (1997). Effect of amorphous silicon dioxide on drug dissolution. J Pharm Sci, 68, 560–565.